Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IBS-D (Diarrhea-predominant)”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Not applicableStudy completedNCT01257477
What this trial is testing

LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome
Prometheus Laboratories 400
Testing effectiveness (Phase 2)Study completedNCT01274000
What this trial is testing

Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients

Who this might be right for
Irritable Bowel Syndrome
Astellas Pharma Inc 409
Not applicableStudy completedNCT04898257
What this trial is testing

Effect of Lactibiane Tolerance® to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Patients

Who this might be right for
IBS - Irritable Bowel Syndrome
Larena SAS 30
Testing effectiveness (Phase 2)Study completedNCT00394173
What this trial is testing

Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhea (IBS-D)
Novartis 180
Testing effectiveness (Phase 2)Ended earlyNCT01887002
What this trial is testing

Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome (IBS)
Ono Pharma USA Inc 39
Not applicableNot Yet RecruitingNCT07425145
What this trial is testing

Transcutaneous Electrical Acustimulation for IBS-D: A Multicenter Study

Who this might be right for
IBS, Diarrhea Predominant
First People's Hospital of Foshan 200
Testing effectiveness (Phase 2)Study completedNCT00230581
What this trial is testing

8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS

Who this might be right for
Irritable Bowel Syndrome
Dynogen Pharmaceuticals 88
Early research (Phase 1)Looking for participantsNCT06960369
What this trial is testing

Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea (IBS-D)Repetitive Transcranial Magnetic Stimulation (rTMS)+3 more
The First Affiliated Hospital of Soochow University
Not applicableStudy completedNCT00616200
What this trial is testing

Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
University of North Carolina, Chapel Hill 17
Testing effectiveness (Phase 2)Ended earlyNCT04043455
What this trial is testing

Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)

Who this might be right for
Irritable Bowel Syndrome
Arena Pharmaceuticals 273
Post-approval studies (Phase 4)Study completedNCT01316718
What this trial is testing

Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhoea
University of Nottingham 108
Testing effectiveness (Phase 2)Looking for participantsNCT06727422
What this trial is testing

Efficacy of Rifaximin With NAC in IBS-D

Who this might be right for
IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)
Mark Pimentel, MD 225
Post-approval studies (Phase 4)Study completedNCT00370032
What this trial is testing

Study to Assess the Effect Of Alosetron On Mucosal Blood Flow

Who this might be right for
Irritable Colon
GlaxoSmithKline 49
Very early researchUnknownNCT04312477
What this trial is testing

Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl Syndrome

Who this might be right for
Diarrhea-predominant Irritable Boewl Syndrome
Xiyuan Hospital of China Academy of Chinese Medical Sciences 60
Not applicableStudy completedNCT05754177
What this trial is testing

Safety and Efficacy of a Probiotic Supplement in IBS-D

Who this might be right for
Irritable Bowel Syndrome With DiarrheaIrritable Bowel Syndrome
The Archer-Daniels-Midland Company 46
Not applicableUnknownNCT05593367
What this trial is testing

Effects of Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D Patients

Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
Second Affiliated Hospital of Xi'an Jiaotong University 80
Not applicableStudy completedNCT02609529
What this trial is testing

SBI in Children With d-IBS

Who this might be right for
Irritable Bowel Syndrome
Louisiana State University Health Sciences Center in New Orleans 20
Not applicableStudy completedNCT07052890
What this trial is testing

Curcumin, Vitamin D and Green Tea in IBS-D

Who this might be right for
Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome With Diarrhea (IBS-D)
Dr Anthony Hobson 78
Very early researchUnknownNCT05369884
What this trial is testing

Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D

Who this might be right for
Non-erosive Reflux DiseaseDiarrhea-Predominant Irritable Bowel Syndrome
Xiyuan Hospital of China Academy of Chinese Medical Sciences 216
Testing effectiveness (Phase 2)Study completedNCT03977155
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Diarrhea-predominant Irritable Bowel Syndrome
Boston Pharmaceuticals 133
Load More Results
400